baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

COCHLEAR LTD/ AU000000COH5 /

2024-06-07 2:14:15 PM	Chg. +0.950	Volume	Bid2:43:46 PM	Ask2:43:46 PM	Market Capitalization	Dividend Y.	P/E Ratio
202.300EUR	+0.47%	- Turnover: -	200.900Bid Size: 13	202.400Ask Size: 13	13.35 bill.EUR	-	-

GlobeNewswire 06-06 Envoy Medical Announces Inclusion in the MSCI USA Micro Cap Index

GlobeNewswire 06-05 Newly Published Peer-Reviewed Article Highlights Advances in Fully Implanted Cochlear Implant Techno...

GlobeNewswire 05-15 Envoy Medical Reports First Quarter 2024 Results

GlobeNewswire 05-14 Fennec Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire 05-08 Latest DB-OTO Results Show Dramatically Improved Hearing to Normal Levels in a Child with Profound G...

GlobeNewswire 04-24 Envoy Medical to Present at the Planet MicroCap Showcase: Vegas 2024

GlobeNewswire 04-03 Envoy Medical to Participate in the LD Micro Invitational XIV Conference April 8 - 9, 2024

GlobeNewswire 04-02 Envoy Medical Reports Fourth Quarter and Full Year 2023 Financial Results

GlobeNewswire 03-21 Fennec Pharmaceuticals Reports Full Year and Fourth Quarter 2023 Financial Results and Provides Busi...

GlobeNewswire 03-20 ACELYRIN, INC. Announces Positive Phase 1/2 Proof-of-Concept Data for Lonigutamab, First Subcutaneou...

GlobeNewswire 03-12 Envoy Medical to Participate in the 36th Annual ROTH Conference

GlobeNewswire 03-04 Envoy Medical Secures Up To $10 Million Term Debt Financing to Advance Upcoming Clinical Trial

GlobeNewswire 02-29 Fennec Pharmaceuticals Reports Preliminary Unaudited Net Revenue for Fourth Quarter and Full-Year 20...

GlobeNewswire 02-07 Newly Introduced Bipartisan Bill Seeks to Clarify Fully Implanted Active Middle Ear Hearing Devices ...

GlobeNewswire 02-05 Envoy Medical CEO Brent Lucas Interviewed by Leading Healthcare Podcast Medical Alley

Newsfile Corp 01-30 Envoy Medical, Inc. to Present at The Microcap Conference

GlobeNewswire 01-22 Envoy Medical Announces Three Additional Patents for Implantable Cochlear Systems

GlobeNewswire 2023-12-05 Fennec Announces Incremental $5 Million Investment from Petrichor

GlobeNewswire 2023-12-04 Envoy Medical to Host Fireside Chat Event December 7

GlobeNewswire 2023-11-20 Envoy Medical Provides Third Quarter 2023 Financial Results and Business Update

GlobeNewswire 2023-11-10 Envoy Medical Announces Publication of Additional Patent for Implantable Cochlear Systems

GlobeNewswire 2023-11-10 Altamira Therapeutics Announces European Patent Office Decision to Grant for Patent Application Cove...

GlobeNewswire 2023-11-09 Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences

GlobeNewswire 2023-11-06 Fennec Pharmaceuticals Announces Third Quarter 2023 Financial Results and Provides Business Update

GlobeNewswire 2023-10-26 Regeneron Shares Preliminary Results Showing Gene Therapy Improves Auditory Responses in Child with ...

COCHLEAR LTD/ AU000000COH5 /

If you wish to receive reply to your feedback, please provide your email address.